Over the past 12 months, information about the SARS-CoV-2 virus (or COVID-19 as it is commonly known) continues to emerge. A wealth of information appears on the website of the U.S. Centers for Disease Control and Prevention (2021) about the virus, management, vaccines, quarantine, and new variants. A search of the National Library of Medicine’s (NLM) National Center for Biotechnology Information’s database (PubMed) identified over 90,000 COVID-19 related articles already in print from around the world (NLM, 2021). Approximately 800 clinical trials examining a variety of biologics for COVID-19 intervention are also underway (all phases) worldwide (NLM ClinicalTrials.gov, 2021).
The role of audiology in the management of COVID-19 patients has emerged as survivors begin to experience a continuance of their health issues post-discharge or a late onset of medical problems. This group of patients has been referred to as COVID-19 “long-haulers.” COVID-19 survivors may also experience auditory/vestibular problems. DiSogra (2020) addresses this issue in detail and offers suggestions for ongoing monitoring.
This article will address whether COVID-19 can be found in cerumen and what precautions need to be taken with current patients and ‘long-haulers.’
Recent Posts
NASEM Releases Report on Meaningful Outcomes in Adult Hearing Health Care
The National Academies of Science, Engineering, and Medicine recently released the report “Measuring Meaningful Outcomes for Adult Hearing Health Outcomes.” The report includes the committee’s…
Trump Administration’s FY 2026 Budget Proposes Deep Cuts and Reorganization for HHS
President Donald Trump has released his fiscal year (FY) 2026 budget proposal for the Department of Health and Human Services (HHS). It reflects a dramatic…
Academy and FLAA Advocate Against Risky Hearing Aid Policies
Last week, Florida Senate Bill (SB) 126 passed in the Senate and moved to the House. Initially introduced alongside House Bill (HB) 101 to remove…